104 related articles for article (PubMed ID: 26637)
1. Interaction of cholera toxin and toxin derivatives with lymphocytes. III. Modulating effects in vivo by cholera toxin on the graft-versus-host reactivity of lymphoid cells: suggested inhibition of suppressor cells.
Lange S; Lindholm L; Holmgren J
Int Arch Allergy Appl Immunol; 1978; 57(4):364-74. PubMed ID: 26637
[TBL] [Abstract][Full Text] [Related]
2. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
Zaleski M
Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
[TBL] [Abstract][Full Text] [Related]
3. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
Kubota E; Ishikawa H; Saito K
J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
[TBL] [Abstract][Full Text] [Related]
4. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Rappaport H
Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
[TBL] [Abstract][Full Text] [Related]
5. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
7. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
[TBL] [Abstract][Full Text] [Related]
8. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
Rózalska B
Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
[TBL] [Abstract][Full Text] [Related]
9. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
Ishikawa H; Kubota E; Saito K
J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of GvH reaction in mice by Listeria monocytogenes.
Rózalska B
Arch Immunol Ther Exp (Warsz); 1987; 35(3):381-8. PubMed ID: 3128245
[TBL] [Abstract][Full Text] [Related]
11. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
12. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
13. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
Maier T; Holda JH; Claman HN
J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
[TBL] [Abstract][Full Text] [Related]
14. A study of the role of macrophages in the graft-versus-host reaction.
Sůla K; Nouza K
Folia Biol (Praha); 1985; 31(1):38-49. PubMed ID: 2982674
[TBL] [Abstract][Full Text] [Related]
15. Splenic suppressor cells in fetal and newborn mice.
Skowron-Cendrzak A; Ptak W
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1091-4. PubMed ID: 35124
[TBL] [Abstract][Full Text] [Related]
16. Tumor acceptance modified by passage in hybrids with graft-versus-host reaction.
Jacobs BB; Parks RC
Exp Hematol; 1978 Nov; 6(10):785-90. PubMed ID: 33818
[TBL] [Abstract][Full Text] [Related]
17. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
Budhecha S; Hamilton BL
J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
[TBL] [Abstract][Full Text] [Related]
18. [Effect of prodigiosin and its combination with immunodepressants on the graft versus host reaction in mice].
Alekhin EK; Shigaev NI
Antibiotiki; 1983 Nov; 28(11):842-5. PubMed ID: 6651274
[TBL] [Abstract][Full Text] [Related]
19. The influence of naturally occurring suppressor cells of systemic graft versus host reaction (GvHR in fetal and newborn mice.
Rybczyńska Z; Sajak A; Skowron-Cendrzak A
Arch Immunol Ther Exp (Warsz); 1981; 29(3):341-5. PubMed ID: 6457582
[TBL] [Abstract][Full Text] [Related]
20. Recovery of T cell populations after acute graft-vs-host reaction.
Hakim FT; Payne S; Shearer GM
J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
